Shell Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Shell Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-60,540	Closed	-$636K	–	1130
2017 Q2	$636K	Hold	60,540	–	–	0.01%	822
2017 Q1	$666K	Sell	60,540 -4,237	-7%	-$49.2K	0.01%	801
2016 Q4	$878K	Sell	64,777 -565	-0.9%	-$7.88K	0.02%	718
2016 Q3	$804K	Sell	65,342 -2,997	-4%	-$35.3K	0.02%	721
2016 Q2	$750K	Sell	68,339 -3,895	-5%	-$43.6K	0.02%	642
2016 Q1	$790K	Sell	72,234 -4,331	-6%	-$54.7K	0.02%	588
2015 Q4	$1.32M	Buy	+76,565	New	+$1.37M	0.03%	485

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Shell Asset Management's SCMP Position: Q3 2017 in Review

Shell Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017, closing a stake of 60,540 shares — an estimated $636K sold.

Shell Asset Management first reported a position in SCMP in Q4 2015 and held it in 7 quarters. The position peaked at $1.32M in Q4 2015. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

Shell Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Shell Asset Management sold 60,540 Sucampo Pharmaceuticals, Inc. shares in Q3 2017, an estimated $636K.
Shell Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2015 and held it in 7 quarters.
Shell Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.32M in Q4 2015.
178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on Shell Asset Management's 13F filing for Q3 2017, filed 18 Oct 2017.